Juan Angel Organero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Juan Angel Organero has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Abderrazzak Douhal
Departamento de Química Física, Facultad de Ciencias Ambientales y Bioquímica, INAMOL, Universidad de Castilla-La Mancha, Avenida Carlos III, S/N, 45071 Toledo, Spain
37 shared publications - Michał Gil
Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland
10 shared publications - Boiko Cohen
Departamento de Química Física, Facultad de Ciencias Ambientales y Bioquímica, and INAMOL, Universidad de Castilla-La Mancha, Avenida Carlos III, S/N, 45071 Toledo, Spain
9 shared publications - Mikel Sanz
Instituto de Química Física Rocasolano, CSIC, Serrano 119, 28006 Madrid, Spain
9 shared publications A. Douhal
Departamento de Química Física, Sección de Químicas, Facultad de Ciencias del Medio Ambiente, Universidad de CastillaLa Mancha, Avenida Carlos III, S.N., 45071 Toledo, Spain
8 shared publications- Cristina Martín
Departamento de Química Física Facultad de Ciencias Ambientales y Bioquímica, and INAMOL Universidad de Castilla‐La Mancha Toledo Spain
6 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 321
Half-sandwich Ir(III) and Rh(III) complexes bearing a π-extended pyrene-based N^N-ligand: Metal- and monodentate ligand influence on photodynamic therapy
- 23 October 2026
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 321
Open AccessHalf-sandwich Ir(III) and Rh(III) complexes bearing a π-extended pyrene-based N^N-ligand: Metal- and monodentate ligand influence on photodynamic therapy
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Inorganic Chemistry Frontiers
π-Extended biscyclometalated Ir( iii ) and Rh( iii ) complexes as highly active and versatile visible-light photocatalysts
π-Extended bis-cyclometalated Ir( iii ) and Rh( iii ) complexes enable efficient visible-light-driven organic transformations.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Inorganic Chemistry Frontiers
Open Accessπ-Extended biscyclometalated Ir( iii ) and Rh( iii ) complexes as highly active and versatile visible-light photocatalysts
π-Extended bis-cyclometalated Ir( iii ) and Rh( iii ) complexes enable efficient visible-light-driven organic transformations.
- Open Access
All‐Small‐Molecule Ternary Organic Solar Cell with 16.35% Efficiency Enabled by Chlorinated Terminal Units
In the last few years, there have been notable developments in organic solar cells using both small molecule donor and acceptor. It has been noted that adding halogens to the end groups of small molecules could enhance the film structure and, consequently, the performance of the devices. In this study, three novel small molecule donors are created. The molecules include a vinyl‐CPDT oligomer with three units, with end‐caps made up of indanedione groups and containing four H, four Cl, and four F substituents. The purpose of the study is to investigate how the halogen substituent affects the photovoltaic characteristics of binary devices made with the non‐fullerene acceptor (NFA) TOCR2 as the acceptor. Having the halogen in the device enhances its effectiveness, and FG5, which has 4‐Cl substituents in the end groups, shows the highest efficiency among all devices with a PCE of 14.39%. Incredibly, the ternary device that is created in normal atmospheric conditions with chloro‐substituted FG5 as the donor, TOCR2 as the acceptor, and the wide band gap NFA DICTF as the third element shows significantly improved efficiency, achieving PCE values of up to 16.35%.
Open AccessAll‐Small‐Molecule Ternary Organic Solar Cell with 16.35% Efficiency Enabled by Chlorinated Terminal Units
In the last few years, there have been notable developments in organic solar cells using both small molecule donor and acceptor. It has been noted that adding halogens to the end groups of small molecules could enhance the film structure and, consequently, the performance of the devices. In this study, three novel small molecule donors are created. The molecules include a vinyl‐CPDT oligomer with three units, with end‐caps made up of indanedione groups and containing four H, four Cl, and four F substituents. The purpose of the study is to investigate how the halogen substituent affects the photovoltaic characteristics of binary devices made with the non‐fullerene acceptor (NFA) TOCR2 as the acceptor. Having the halogen in the device enhances its effectiveness, and FG5, which has 4‐Cl substituents in the end groups, shows the highest efficiency among all devices with a PCE of 14.39%. Incredibly, the ternary device that is created in normal atmospheric conditions with chloro‐substituted FG5 as the donor, TOCR2 as the acceptor, and the wide band gap NFA DICTF as the third element shows significantly improved efficiency, achieving PCE values of up to 16.35%.
- Open Access
- 29 May 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 12 (25) , 9112-9129
Unravelling the photobehavior of a 2,1,3-benzothiadiazole-based HOF and its molecular units: experimental and theoretical insights into their spectroscopic properties in solution and in the solid state
Revealing the photobehaviour of a new BTD-based HOF shows the occurrence of intramolecular charge-transfer and intermolecular proton-transfer photoevents leading to different emission spectra and lifetimes when compared to the molecular units.
- 29 May 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 12 (25) , 9112-9129
Open AccessUnravelling the photobehavior of a 2,1,3-benzothiadiazole-based HOF and its molecular units: experimental and theoretical insights into their spectroscopic properties in solution and in the solid state
Revealing the photobehaviour of a new BTD-based HOF shows the occurrence of intramolecular charge-transfer and intermolecular proton-transfer photoevents leading to different emission spectra and lifetimes when compared to the molecular units.
- 17 July 2023
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 28 (6) , 531-547
Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents
In the treatment of hormone-dependent cancers, aromatase inhibitors (AI) are receiving increased attention due to some undesirable effects such as the risk of endometrial cancer and thromboembolism of SERMs (selective estrogen receptor modulators). Letrozole is the most active AI with 99% aromatase inhibition. Unfortunately, this compound also exhibits some adverse effects such as hot flashes and fibromyalgias. Therefore, there is an urgent need to explore new types of AIs that retain the same—or even increased—antitumor ability. Inspired by the letrozole structure, a set of new derivatives has been synthesized that include a ferrocenyl moiety and different heterocycles. The derivative that contains a benzimidazole ring, namely compound 6, exhibits a higher aromatase inhibitory activity than letrozole and it also shows potent cytostatic behavior when compared to other well-established aromatase inhibitors, as demonstrated by dose–response, cell cycle, apoptosis and time course experiments. Furthermore, 6 promotes the inhibition of cell growth in both an aromatase-dependent and -independent fashion, as indicated by the study of A549 and MCF7 cell lines. Molecular docking and molecular dynamics calculations on the interaction of 6 or letrozole with the aromatase binding site revealed that the ferrocene moiety increases the van der Waals and hydrophobic interactions, thus resulting in an increase in binding affinity. Furthermore, the iron atom of the ferrocene fragment can form a metal-acceptor interaction with a propionate fragment, and this results in a stronger coupling with the heme group—a possibility that is consistent with the strong aromatase inhibition of 6. Graphical abstract
- 17 July 2023
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 28 (6) , 531-547
Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents
In the treatment of hormone-dependent cancers, aromatase inhibitors (AI) are receiving increased attention due to some undesirable effects such as the risk of endometrial cancer and thromboembolism of SERMs (selective estrogen receptor modulators). Letrozole is the most active AI with 99% aromatase inhibition. Unfortunately, this compound also exhibits some adverse effects such as hot flashes and fibromyalgias. Therefore, there is an urgent need to explore new types of AIs that retain the same—or even increased—antitumor ability. Inspired by the letrozole structure, a set of new derivatives has been synthesized that include a ferrocenyl moiety and different heterocycles. The derivative that contains a benzimidazole ring, namely compound 6, exhibits a higher aromatase inhibitory activity than letrozole and it also shows potent cytostatic behavior when compared to other well-established aromatase inhibitors, as demonstrated by dose–response, cell cycle, apoptosis and time course experiments. Furthermore, 6 promotes the inhibition of cell growth in both an aromatase-dependent and -independent fashion, as indicated by the study of A549 and MCF7 cell lines. Molecular docking and molecular dynamics calculations on the interaction of 6 or letrozole with the aromatase binding site revealed that the ferrocene moiety increases the van der Waals and hydrophobic interactions, thus resulting in an increase in binding affinity. Furthermore, the iron atom of the ferrocene fragment can form a metal-acceptor interaction with a propionate fragment, and this results in a stronger coupling with the heme group—a possibility that is consistent with the strong aromatase inhibition of 6. Graphical abstract
- 20 April 2018
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 20 (20) , 14182-14191
Structural and photodynamic properties of the anti-cancer drug irinotecan in aqueous solutions of different pHs
This work reports on photophysical studies of the irinotecan (IRT) anti-cancer drug in water solutions of different acidities (pH = 1.11–9.46). We found that IRT co-exists as mono-cationic (C1), di-cationic (C2), or neutral (N) forms. The population of each prototropic species depends on the pH of the solution. At pH = 1.11–3.01, the C1 and C2 structures are stabilized. At pH = 7.00, the most populated species is C1, while at pH values larger than 9.46 the N form is the most stable species. In the 1.11–2.61 pH range, the C1* emission is efficiently quenched by protons to give rise to the emission from C2*. The dynamic quenching constant, KD, is ∼32 M−1. While the diffusion governs the rate of excited-state proton-transfer (ESPT) under these conditions, the reaction rate increases with the proton concentration. A two-step diffusive Debye–Smoluchowski model was applied at pH = 1.11–2.61 to describe the protonation of C1*. The ESPT time constants derived for C1* are 382 and 1720 ps at pH = 1.11 and 1.95, respectively. We found that one proton species is involved in the protonation of C1* to give C2*, in the analyzed acidic pH range. Under alkaline conditions (pH = 9.46), the N form is the most stable structure of IRT. These results indicate the influence of the pH of the medium on the structural and dynamical properties of IRT in water solution. They may help to provide a better understanding on the relationship between the structure and biological activity of IRT.
- 20 April 2018
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 20 (20) , 14182-14191
Structural and photodynamic properties of the anti-cancer drug irinotecan in aqueous solutions of different pHs
This work reports on photophysical studies of the irinotecan (IRT) anti-cancer drug in water solutions of different acidities (pH = 1.11–9.46). We found that IRT co-exists as mono-cationic (C1), di-cationic (C2), or neutral (N) forms. The population of each prototropic species depends on the pH of the solution. At pH = 1.11–3.01, the C1 and C2 structures are stabilized. At pH = 7.00, the most populated species is C1, while at pH values larger than 9.46 the N form is the most stable species. In the 1.11–2.61 pH range, the C1* emission is efficiently quenched by protons to give rise to the emission from C2*. The dynamic quenching constant, KD, is ∼32 M−1. While the diffusion governs the rate of excited-state proton-transfer (ESPT) under these conditions, the reaction rate increases with the proton concentration. A two-step diffusive Debye–Smoluchowski model was applied at pH = 1.11–2.61 to describe the protonation of C1*. The ESPT time constants derived for C1* are 382 and 1720 ps at pH = 1.11 and 1.95, respectively. We found that one proton species is involved in the protonation of C1* to give C2*, in the analyzed acidic pH range. Under alkaline conditions (pH = 9.46), the N form is the most stable structure of IRT. These results indicate the influence of the pH of the medium on the structural and dynamical properties of IRT in water solution. They may help to provide a better understanding on the relationship between the structure and biological activity of IRT.
- 3 November 2017
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 56 (22) , 13679-13696
Synthesis and Biological Evaluation of Ru(II) and Pt(II) Complexes Bearing Carboxyl Groups as Potential Anticancer Targeted Drugs
The synthesis and characterization of Pt(II) (1 and 2) and Ru(II) arene (3 and 4) or polypyridine (5 and 6) complexes is described. With the aim of having a functional group to form bioconjugates, one uncoordinated carboxyl group has been introduced in all complexes. Some of the complexes were selected for their potential in photodynamic therapy (PDT). The molecular structures of complexes 2 and 5, as well as that of the sodium salt of the 4′-(4-carboxyphenyl)-2,2′:6′,2″-terpyridine ligand (cptpy), were determined by X-ray diffraction. Different techniques were used to evaluate the binding capacity to model DNA molecules, and MTT cytotoxicity assays were performed against four cell lines. Compounds 3, 4, and 5 showed little tendency to bind to DNA and exhibited poor biological activity. Compound 2 behaves as bonded to DNA probably through a covalent interaction, although its cytotoxicity was very low. Compound 1 and possibly 6, both of which contain a cptpy ligand, were able to intercalate with DNA, but toxicity was not observed for 6. However, compound 1 was active in all cell lines tested. Clonogenic assays and apoptosis induction studies were also performed on the PC-3 line for 1. The photodynamic behavior for complexes 1, 5, and 6 indicated that their nuclease activity was enhanced after irradiation at λ = 447 nm. The cell viability was significantly reduced only in the case of 5. The different behavior in the absence or presence of light makes complex 5 a potential prodrug of interest in PDT. Molecular docking studies followed by molecular dynamics simulations for 1 and the counterpart without the carboxyl group confirmed the experimental data that pointed to an intercalation mechanism. The cytotoxicity of 1 and the potential of 5 in PDT make them good candidates for subsequent conjugation, through the carboxyl group, to “selected peptides” which could facilitate the selective vectorization of the complex toward receptors that are overexpressed in neoplastic cell lines.
- 3 November 2017
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 56 (22) , 13679-13696
Synthesis and Biological Evaluation of Ru(II) and Pt(II) Complexes Bearing Carboxyl Groups as Potential Anticancer Targeted Drugs
The synthesis and characterization of Pt(II) (1 and 2) and Ru(II) arene (3 and 4) or polypyridine (5 and 6) complexes is described. With the aim of having a functional group to form bioconjugates, one uncoordinated carboxyl group has been introduced in all complexes. Some of the complexes were selected for their potential in photodynamic therapy (PDT). The molecular structures of complexes 2 and 5, as well as that of the sodium salt of the 4′-(4-carboxyphenyl)-2,2′:6′,2″-terpyridine ligand (cptpy), were determined by X-ray diffraction. Different techniques were used to evaluate the binding capacity to model DNA molecules, and MTT cytotoxicity assays were performed against four cell lines. Compounds 3, 4, and 5 showed little tendency to bind to DNA and exhibited poor biological activity. Compound 2 behaves as bonded to DNA probably through a covalent interaction, although its cytotoxicity was very low. Compound 1 and possibly 6, both of which contain a cptpy ligand, were able to intercalate with DNA, but toxicity was not observed for 6. However, compound 1 was active in all cell lines tested. Clonogenic assays and apoptosis induction studies were also performed on the PC-3 line for 1. The photodynamic behavior for complexes 1, 5, and 6 indicated that their nuclease activity was enhanced after irradiation at λ = 447 nm. The cell viability was significantly reduced only in the case of 5. The different behavior in the absence or presence of light makes complex 5 a potential prodrug of interest in PDT. Molecular docking studies followed by molecular dynamics simulations for 1 and the counterpart without the carboxyl group confirmed the experimental data that pointed to an intercalation mechanism. The cytotoxicity of 1 and the potential of 5 in PDT make them good candidates for subsequent conjugation, through the carboxyl group, to “selected peptides” which could facilitate the selective vectorization of the complex toward receptors that are overexpressed in neoplastic cell lines.
- 14 February 2014
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 118 (15) , 8217-8226
Exploring the Photobehavior of Nanocaged Monomers and H- and J-Aggregates of a Proton-Transfer Dye within NaX and NaY Zeolites
- 14 February 2014
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 118 (15) , 8217-8226
Exploring the Photobehavior of Nanocaged Monomers and H- and J-Aggregates of a Proton-Transfer Dye within NaX and NaY Zeolites
- 31 May 2013
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 117 (23) , 11906-11919
Real-Time Photodynamics of Squaraine-Based Dye-Sensitized Solar Cells with Iodide and Cobalt Electrolytes
- 31 May 2013
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 117 (23) , 11906-11919
Real-Time Photodynamics of Squaraine-Based Dye-Sensitized Solar Cells with Iodide and Cobalt Electrolytes
- 13 July 2012
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 116 (29) , 15385-15395
Competitive Ultrafast Electron and Proton Transfer Reactions within Titania and Silica Mesoporous Materials
- 13 July 2012
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry C
- Vol. 116 (29) , 15385-15395
Competitive Ultrafast Electron and Proton Transfer Reactions within Titania and Silica Mesoporous Materials